CLINICAL MANUFACTURE AND SUPPLY AGREEMENTClinical Manufacture and Supply Agreement • September 27th, 2013 • Ocera Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS CLINICAL MANUFACTURE AND SUPPLY AGREEMENT (the “Agreement”) is entered into as of December 22, 2005 (the “CSA Effective Date”), by and between OCERA THERAPEUTICS, INC. (“Ocera”), a Delaware corporation, having an address of 11622 El Camino Real, Suite 100, San Diego, CA 92130, United States of America, and KUREHA CORPORATION, a Japanese corporation (“Kureha”), having an address of 3-3-2, Nihonbashi Hama-cho, Chuo-ku, Tokyo 103-8552, Japan.
WITNESSETHClinical Manufacture and Supply Agreement • May 14th, 2001 • Neorx Corp • In vitro & in vivo diagnostic substances
WITNESSETHClinical Manufacture and Supply Agreement • May 9th, 2000 • Neorx Corp • In vitro & in vivo diagnostic substances • Washington
